Skip to main content
Equibles

WINTON GROUP Ltd

Position in XFOR — X4 Pharmaceuticals, Inc

CIK 1612063 LONDON, X0
Back to XFOR Full portfolio

Position in XFOR

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$67,248
+$23,470 QoQ
Shares Held
14,400
+35.8% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 89 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XFOR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WINTON GROUP Ltd holds $97,029,578 across 91 Biotechnology names. XFOR ranks #80 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 254,408 $28,839,690
2 FTRE
Fortrea Holdings Inc.
 389,155 $6,771,297
3 EXEL
Exelixis, Inc.
 99,834 $5,431,967
4 TECH
BIO-TECHNE Corp
 67,227 $4,749,587
5 HALO
Halozyme Therapeutics, Inc.
 60,348 $4,723,437
6 VKTX
Viking Therapeutics, Inc.
 90,546 $3,532,199
7 ALNY
Alnylam Pharmaceuticals, Inc.
 7,880 $2,372,116
8 TRVI
Trevi Therapeutics, Inc.
 106,852 $1,992,789

All Filings in XFOR

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $67,248 14,400
2026-03-31 $43,778 10,600